Heat thErapy And mobiLity in COVID-19 Survivors
Sponsor: University of Nebraska • ClinicalTrials.gov ID: NCT06928116
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".
Interventions
-
Heat therapy
(Behavioral)
At home lower body heat therapy
-
Sham Control
(Behavioral)
Sham Thermoneutral
-
Walking
(Behavioral)
Walking intervention
Eligibility criteria
Conditions
Locations
- University of Nebraska Omaha — Omaha, Nebraska, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record